Research News - November 20, 2015

Check out the latest issue and find out how:

• ServiceNow is transforming the way users use IS - as a service rather than a series of IT products
• Partners IS is helping Partners eCare to be a “good customer” of Epic
• the upgrade to Internet Explorer is going
• Important policies and procedures are to the success of information security efforts of the Lighthouse Project

Visit Policy Central to view all active policies for Partners HealthCare, Spaulding Rehabilitation Network, and Partners Community Physicians Organization. A user guide is available in ServiceNow: https://partnershealthcare.service-now.com/kb_view.do?sysparm_article=KB0023481.                          

How do I access Policy Central?
Go to Partners Applications > Policies and Procedures > Partners Policies and Procedures > Select your institution from the dropdown menu.

If you have any questions, please contact the IS Service Desk.

Program Duration: July 2016 - May 2018     

Applications Due: January 8, 2016

This two-year certificate program consists of a didactic curriculum and a mentored clinical/translational (C/T) research project with a Harvard-based mentor. It is designed primarily for clinicians and researchers seeking to strengthen their knowledge in the conduct of C/T investigation.

For more information, please click here.

Please click here to read the latest news from the Patient-Centered Outcomes Research Institute.

Tuesday, December 1, 2015, 3:30 - 4:30 pm, Main Campus, details provided upon registration
The Center for Faculty Development’s Office for Research Career Development presents a new initiative for MGH Postdocs

The Career Pathways for Postdocs (CPP) initiative is designed to help MGH research fellows explore career interests while continuing their research at the hospital. Through the CPP program, postdoctoral research fellows can learn about a new career path such as science communications, program development/management, policy/government relations, and others. Most opportunities consist of 4-6 hours per week (8-12 weeks duration) that can be scheduled to accommodate a postdoc’s required time in the laboratory.

Please click here for more information (see below to register).

NOTE: Attendance at this information session, and an MGH appointment as a Research Fellow are required to apply for the CPP.

Speakers: Ann Skoczenski, PhD, Senior Program Manager, Center for Faculty Development, and collaborating office representatives

Please click here to register by Tue, Nov 24.

Thursday, December 3, 1:30 - 2:30 pm, O’Keeffe Auditorium

“Exploring the Experience and Impact of Therapeutic Touch Treatments to Nurse Colleagues”
Presented by:   Amanda Bulette Coakley, RN, PhD, FNAP, Staff Specialist, Department of Nursing, Patient Care Services

This presentation will discuss how nurses may benefit from therapeutic touch as an alternative method of self-healing, particularly nurses who provide care for acute and chronically ill patients.

Norman Knight Nursing Center for Clinical and Professional Development at Massachusetts General Hospital (OH-239, 10/1/2017) is an approved provider of continuing nursing education by the Ohio Nurses Association (OBN-001-91), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

The learner must stay for the entire program and submit a completed evaluation to obtain contact hours.

Monday, December 7, 12:00 - 1:00 PM, Simches Auditorium (3.110)
Broadcast to Isselbacher Auditorium (CNY-149, 7th Floor)

Crowd Funding
Michele Gagne, Senior Director, Information Systems, MGH Development Office

What’s on Your Mind?
An Open Discussion with the Elected ECOR Representatives

(Lunch available at 11:45 AM)

All MGH Researchers welcome!

Tuesday, February 2, 2016, 1:30 - 5:00pm, Simches Room 3.110

Sponsored by the MGH Division of Clinical Research and the Harvard Catalyst

This introductory course is intended for clinicians, investigators, graduate and medical students, and clinical research staff with an interest in functional genomics and precision medicine.
It will introduce fundamental language and concepts including basic concepts behind analytical tools, sample preparation, quantitative considerations, protein-protein interaction networks, post-translational modifications, data analysis, biomarker discovery and validation, translational introduction of diagnostic and prognostic biomarkers into the clinic, approaches to understand basic disease mechanisms and to identify potential novel drug targets, as well as applications for personalized medicine.

Key principles necessary for basic, clinical, and translational researchers to design proteomic and metabolomics studies and to perform and analyze data will be discussed.

Registration is required. Contact Jillian Tonelli with any questions.

Preliminary applications are now being accepted by the Executive Committee on Research (ECOR) for the NIH Director’s Early Independence Awards.

What is it?
The NIH Director’s Early Independence Award Program supports exceptional investigators who wish to pursue independent research directly after completion of their terminal doctoral/research degree or clinical residency, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career.

MGH is eligible to nominate two candidates to apply to NIH for this award.

When is the deadline?  
MGH internal preliminary applications: November 23, 2015 – 5:00 PM

How do I learn more and apply?
Click here to for more information and to apply for this award.

The Executive Committee on Research (ECOR) is accepting applications for the December 1st deadline for the Deliberative Interim Support Funding.  December is the 1st of three standing deadlines for these awards in Fiscal Year 2016.  The next deadline will be April 1, 2016.  

What are they?
Deliberative Interim Support Funding
This is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense).  Investigators must have applied for independent, long-term support (R01, R21, U01 and P01).  The Deliberative Interim Support process is open to:

1. Investigators whose grants were not scored or whose scores were not translated into a percentile ranking.
2. Investigators whose grants received scores >20th percentile.
3. Investigators who were awarded Formulaic Bridge Funding (grants with scores < or = 20th percentile), and are now requesting additional financial support (in excess of $75,000 for RO1s, and $37,500 for R21s).
4. Investigators who have already received Formulaic Bridge Funding or Deliberative Interim Support on their A0 grant application and are now requesting support for their A1 or A0 resubmission.  Investigators in this category must apply through the Deliberative Interim Support process for their A1 and A0 resubmission regardless of the score they received on their resubmitted grant.

When is the deadline?
Tuesday, December 1, 2015 - 5:00 PM

How do I learn more and apply?
Deliberative Interim Support Funding - Click here

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these funding opportunities.  Note that proposals are still routed through the standard InfoEd/Research Management process.

• Arthritis Research Grants, Arthritis National Research Foundation (ANRF)
• General Repurposing Research Request for Proposals, Cures Within Reach

Please click here for further details on these funding opportunities.

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

• Name of the Principal Investigator with appropriate contact information
• A descriptive title of the potential application
• Brief description of the project
• Brief description of why you specifically should be selected to receive institutional nomination for this award

In the event that there is more than one MGH investigators interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

• Superfund Hazardous Substance Research and Training Program (P42)
• International Centers of Excellence for Malaria Research (U19)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.

For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm

MGH ECOR Deliberative Interim Support Funding (ISF)
Application Deadline: December 1

Massachusetts Eye and Ear Gliklich Innovation Scholars Program
Application Deadline: February 1, 2016

Boston Biomedical Innovation Center (B-BIC) Accepting PILOT & DRIVE Grant Pre-Proposals

Innovation at Partners HealthCare: Fall Newsletter

Basic Biostatistics for Clinical Research - January 7, 14, 21, 28, February 4

Introduction to ‘Omics’ Research - March 7 - 11

Looking for something you saw in a previous Research News release? Check out our archive!